Task B16: Synthesis of Galidesivir Triphosphate and other anabolites

非临床传染病干预剂开发服务计划提供服务，促进针对传染病病原体和/或毒素的有前景的治疗药物的临床前产品开发。服务包括：临床前产品开发计划和评估；铅识别和开发；化学和GMP制造；体外和体内临床前微生物学、安全性、毒理学和药代动力学。

The Non-clinical Services for Development of Interventional Agents for Infectious Diseases program provides services to facilitate preclinical product development of promising therapeutics for infectious disease-causing pathogens and/or toxins. Services include: preclinical product development planning and evaluation; lead identification and development; chemistry and GMP manufacturing; in vitro and in vivo preclinical microbiological, safety, toxicology and pharmacokinetics.